中心性浆液性脉络膜视网膜病变中视网膜下液持续时间与临床结局:至光动力疗法时间的分析
回顾性病例系列纳入94例(94眼)中心性浆液性脉络膜视网膜病变患者,测量等待光动力疗法(PDT)期间最佳矫正视力与视网膜层厚度变化,并分析至PDT时间与12个月结局的关联。等待期间外核层显著变薄(平均减少1.9±4.4 μm,P=3.4×10⁻⁵),等待时间越长变薄越明显(校正β=-0.04,P=1.3×10⁻⁶),但等待时长与12个月治疗结局无显著关联。作者提示应警惕视网膜下液暴露超过1至2个月。
要点
- 等待PDT期间外核层显著变薄,平均减少1.9±4.4 μm(P=3.4×10⁻⁵)。
- 等待时间越长外核层变薄越明显(校正β=-0.04,P=1.3×10⁻⁶)。
- 等待时长与12个月治疗结局无显著关联。
核心结论
- 作者认为应警惕视网膜下液暴露超过1至2个月,因其可能诱导外核层变薄。
研究设计与样本
- 回顾性病例系列,纳入2016年1月至2024年8月期间接受PDT的连续性中心性浆液性脉络膜视网膜病变患者,排除等待PDT期间视网膜下液自行消退者,共94例(94眼)。
主要发现
- 94例患者平均年龄57.6±12.2岁,基线平均最佳矫正视力0.18±0.24 logMAR(Snellen 20/30),平均等待期50.8±50.2天。
- 等待期间外核层显著变薄,平均减少1.9±4.4 μm(P=3.4×10⁻⁵)。
- 等待时间越长外核层变薄越明显:粗模型β=-0.04(P=3.5×10⁻⁶),校正模型β=-0.04(P=1.3×10⁻⁶)。
- 等待时长与12个月治疗结局无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the effect of prolonged serous retinal detachment (SRD) during the waiting period for photodynamic therapy (PDT) on clinical outcomes in patients with central serous chorioretinopathy (CSC). DESIGN: Retrospective case series. SUBJECTS: Consecutive patients with CSC who underwent PDT between January 2016 and August 2024. Patients whose SRD resolved spontaneously while awaiting PDT were excluded. METHODS: We measured the best-corrected visual acuity (BCVA) and retinal layer thickness at baseline and on the day of PDT. We evaluated (1) the changes in these parameters during the waiting period and (2) the association between the duration of this period and the outcomes. MAIN OUTCOME MEASURES: Associations of the time-to-PDT with 12-month BCVA, SRD remission at 12 months, and changes in retinal layer thickness during the waiting period. RESULTS: Ninety-four patients (94 eyes) with CSC were included, with a mean age of 57.6 ± 12.2 years, a mean BCVA of 0.18 ± 0.24 logMAR (Snellen: 20/30), and a mean waiting period of 50.8 ± 50.2 days. The outer nuclear layer thinned significantly during the waiting period (mean reduction = 1.9 ± 4.4 μm, P = 3.4 × 10-5), and longer waiting times were associated with greater thinning (crude: β = -0.04, P = 3.5 × 10-6; adjusted: β = -0.04, P = 1.3 × 10-6). However, waiting duration was not significantly associated with 12-month treatment outcomes. CONCLUSIONS: Our findings suggest that caution is warranted against prolonged subretinal fluid exposure beyond 1 to 2 months, as it may induce outer nuclear layer thinning.
引用
- Funatsu R, Mihara N, Miyake S, et al. Subretinal Fluid Duration and Clinical Outcomes in Central Serous Chorioretinopathy: An Analysis of Time-to-Photodynamic Therapy. Am J Ophthalmol. 2025. PMID: 41314275. doi:10.1016/j.ajo.2025.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。